Clinical observation of Placenta Polypeptide Injection combined with mannatide in prevention of postoperative infection of fracture patients
Bai-gang ZHOU,Xi-jing HE,Hong-wei FENG
DOI: https://doi.org/10.7501/j.issn.1674-5515.2016.08.028
2016-01-01
Abstract:Objective To observe the clinical effects of Placenta Polypeptide Injection combined with mannatide in prevention of postoperative infection of fracture patients.Methods Patients (80 cases) with fracture in NO. 215 Hospital of Shaanxi Nuclear Industry from January 2014 to January 2015 were randomly divided into control and treatment groups, and each group had 40 cases. The patients in the control group were iv administered with Mannatide for injection on the basis of treatment, 10 mg added into 5% glucose solution 250 mL, once daily. The patients in the treatment group were iv administered with Placenta Polypeptide Injection on the basis of the control group, 8 mL added into normal saline 250 mL, once daily. The patients in two groups were treated for 14 d. After treatment, the hospital stay time, exudates disappeared time, the infection control time, skin healing time, bone healing time, and postoperative infection rate in two groups were compared. And the changes of TNF-α, IL-1, IL-6, CRP, WBC, CD3+, CD4+, CD4+/CD8+ and NK in two groups before and after treatment were compared.Results After treatment, the hospital stay time, exudates disappeared time, the infection control time, skin healing time, bone healing time, and postoperative infection rate were lower than those in the control group, and there were differences between two groups (P < 0.05). After treatment, TNF-α, IL-1, IL-6, CRP, and WBC were significantly increased, and CD3+, CD4+, CD4+/CD8+, and NK were significantly increased, and the difference was statistically significant in the same group (P < 0.05). After treatment, those observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups (P < 0.05).Conclusion Placenta Polypeptide Injection combined with mannatide has clinical curative effect in prevention of postoperative infection of fracture patients, and can reduce the postoperative infection rate of patients with fracture, and enhance the immunity of patients, which has a certain clinical application value.